01696.HK
Sisram Medical Ltd
HKSE · Healthcare · Medical - Devices · IL
HKD 1.90
−0.26%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 717.2M | 365.3M | 349.1M | 359.3M | 354.5M |
| Cost of Revenue | 293.4M | 150.2M | 132.4M | 139.8M | 152.3M |
| Gross Profit | 423.7M | 215.1M | 216.7M | 219.5M | 202.2M |
| Operating Expenses | |||||
| R&D Expense | 31.4M | 16.9M | 15.9M | 18.0M | 18.0M |
| SG&A Expense | 337.9M | 165.7M | 165.1M | 159.4M | 128.8M |
| General & Admin Expense | 72.2M | 36.2M | 33.6M | 34.1M | 29.1M |
| Selling & Marketing Expense | 265.6M | 129.5M | 131.5M | 125.3M | 99.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 369.3M | 182.6M | 181.0M | 177.5M | 146.8M |
| Cost and Expenses | 662.7M | 332.8M | 313.5M | 317.2M | 299.0M |
| Operating Income (EBIT) | 54.4M | 32.6M | 35.7M | 42.1M | 55.4M |
| Non-Operating | |||||
| Interest Income | 5.5M | 962.4K | 790.0K | 222.0K | 613.0K |
| Interest Expense | 3.9M | 3.2M | 2.5M | 2.1M | 2.0M |
| Net Interest Income | (5.1M) | (2.3M) | (1.7M) | (1.8M) | (1.4M) |
| Other Non-Op Income/Expense | (5.8M) | (4.0M) | (3.1M) | (4.9M) | (11.2M) |
| Non-Operating Income (excl Interest) | 11.7M | 5.5M | 8.0M | 2.9M | 9.5M |
| EBT (Pre-Tax Income) | 48.6M | 28.6M | 32.5M | 37.1M | 44.2M |
| Income Tax Expense | 7.0M | 3.5M | 3.8M | 4.2M | 4.2M |
| Bottom Line | |||||
| Net Income | 32.0M | 19.0M | 25.1M | 31.5M | 40.2M |
| Earnings from Cont. Ops | 41.6M | 25.0M | 28.8M | 32.9M | 40.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 32.0M | 19.0M | 25.1M | 31.5M | 40.2M |
| Per Share | |||||
| Basic EPS | HK$0.07 | HK$0.04 | HK$0.05 | HK$0.07 | HK$0.09 |
| Diluted EPS | HK$0.07 | HK$0.04 | HK$0.05 | HK$0.07 | HK$0.09 |
| Revenue Per Share | HK$1.53 | HK$0.78 | HK$0.75 | HK$0.77 | HK$0.76 |
| Shares | |||||
| Basic Shares Outstanding | 468.4M | 468.3M | 468.3M | 468.0M | 466.2M |
| Diluted Shares Outstanding | 468.3M | 468.3M | 468.3M | 468.3M | 466.8M |
| Profitability Metrics | |||||
| EBITDA | 67.4M | 38.2M | 38.9M | 53.4M | 58.4M |
| D&A | 24.7M | 11.2M | 11.2M | 14.2M | 12.4M |
| EBIT | 42.7M | 27.0M | 27.7M | 39.2M | 46.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026